ATE278665T1 - Verfahren zur herstellung von n-acyl-3,4- dehydroprolin und n-acyl-3,4-dehydropiperidin-2- carbonsäure derivaten - Google Patents

Verfahren zur herstellung von n-acyl-3,4- dehydroprolin und n-acyl-3,4-dehydropiperidin-2- carbonsäure derivaten

Info

Publication number
ATE278665T1
ATE278665T1 AT00918809T AT00918809T ATE278665T1 AT E278665 T1 ATE278665 T1 AT E278665T1 AT 00918809 T AT00918809 T AT 00918809T AT 00918809 T AT00918809 T AT 00918809T AT E278665 T1 ATE278665 T1 AT E278665T1
Authority
AT
Austria
Prior art keywords
acyl
dehydropiperidine
dehydroproline
producing
carboxylic acid
Prior art date
Application number
AT00918809T
Other languages
German (de)
English (en)
Inventor
Bernd Schaefer
Guenter Helmchen
Uli Kazmaier
Simone Schleich
Helmut Stahr
Volker Wolfart
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of ATE278665T1 publication Critical patent/ATE278665T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00918809T 1999-03-26 2000-03-17 Verfahren zur herstellung von n-acyl-3,4- dehydroprolin und n-acyl-3,4-dehydropiperidin-2- carbonsäure derivaten ATE278665T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913699A DE19913699A1 (de) 1999-03-26 1999-03-26 Verfahren zur Herstellung von 3,4-Dihydroprolinen und 3,4-Dehydropiperidinen
PCT/EP2000/002377 WO2000058284A1 (de) 1999-03-26 2000-03-17 Verfahren zur herstellung von n-acyl-3,4 - dehydroprolin und n-acyl-3,4 - dehydropiperidin-2-carbonsäure derivaten

Publications (1)

Publication Number Publication Date
ATE278665T1 true ATE278665T1 (de) 2004-10-15

Family

ID=7902464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918809T ATE278665T1 (de) 1999-03-26 2000-03-17 Verfahren zur herstellung von n-acyl-3,4- dehydroprolin und n-acyl-3,4-dehydropiperidin-2- carbonsäure derivaten

Country Status (22)

Country Link
US (1) US6579971B1 (enExample)
EP (1) EP1165509B1 (enExample)
JP (1) JP3868210B2 (enExample)
KR (1) KR20010104730A (enExample)
CN (1) CN1345310A (enExample)
AT (1) ATE278665T1 (enExample)
AU (1) AU3962500A (enExample)
BR (1) BR0009330A (enExample)
CA (1) CA2368479C (enExample)
CZ (1) CZ20013456A3 (enExample)
DE (2) DE19913699A1 (enExample)
ES (1) ES2230088T3 (enExample)
HK (1) HK1045156A1 (enExample)
HU (1) HUP0200420A2 (enExample)
IL (1) IL145525A0 (enExample)
MX (1) MXPA01009679A (enExample)
NO (1) NO20014645L (enExample)
RU (1) RU2001129097A (enExample)
TR (1) TR200102747T2 (enExample)
TW (1) TWI276626B (enExample)
WO (1) WO2000058284A1 (enExample)
ZA (1) ZA200107629B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396666C (zh) * 2005-12-14 2008-06-25 郑州大学 (4s)-1-叔丁氧羰基-4-氨基-l-脯氨酸乙酯及其合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291040A (en) * 1979-10-22 1981-09-22 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
JPH09502191A (ja) 1993-09-09 1997-03-04 シエーリング アクチエンゲゼルシヤフト 作用物質およびガスを含有する微粒子
DE19630082A1 (de) * 1996-07-26 1998-01-29 Basf Ag Verfahren zur Herstellung von 3-Pyrrolin-2-carbonsäure-Derivaten
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
DE19723473A1 (de) * 1997-06-04 1998-12-10 Basf Ag Verfahren zur Herstellung von chiralen 3,4-Didehydroprolinen
CA2319433C (en) 1998-02-09 2008-04-22 Bracco Research S.A. Targeted delivery of biologically active media

Also Published As

Publication number Publication date
RU2001129097A (ru) 2004-03-20
CZ20013456A3 (cs) 2002-05-15
AU3962500A (en) 2000-10-16
NO20014645D0 (no) 2001-09-25
MXPA01009679A (es) 2002-03-14
EP1165509B1 (de) 2004-10-06
KR20010104730A (ko) 2001-11-26
CA2368479C (en) 2005-03-01
WO2000058284A1 (de) 2000-10-05
TWI276626B (en) 2007-03-21
CN1345310A (zh) 2002-04-17
NO20014645L (no) 2001-09-25
HUP0200420A2 (hu) 2002-05-29
CA2368479A1 (en) 2000-10-05
TR200102747T2 (tr) 2002-02-21
ES2230088T3 (es) 2005-05-01
BR0009330A (pt) 2002-01-08
IL145525A0 (en) 2002-06-30
ZA200107629B (en) 2002-09-17
DE50008117D1 (de) 2004-11-11
EP1165509A1 (de) 2002-01-02
JP2002540190A (ja) 2002-11-26
US6579971B1 (en) 2003-06-17
HK1045156A1 (zh) 2002-11-15
JP3868210B2 (ja) 2007-01-17
DE19913699A1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
TW197936B (enExample)
DE59903367D1 (de) Perameisensäure und Peressigsäure enthaltendes wässriges Desinfektionsmittel, Verfahren zu dessen Herstellung und dessen Verwendung
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
TW200514783A (en) Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
GB9822473D0 (en) Chemical compounds
DE60042968D1 (de) Zusammensetzungen und methoden zur behandlung lymphoma
ATE268749T1 (de) Verfahren zur herstellung von iopamidol
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
ATE278665T1 (de) Verfahren zur herstellung von n-acyl-3,4- dehydroprolin und n-acyl-3,4-dehydropiperidin-2- carbonsäure derivaten
ATE40573T1 (de) Verfahren zur herstellung von feinverteiltem, hochreaktivem magnesium und dessen verwendung.
DE69629664D1 (de) Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung
ATE258605T1 (de) Verfahren zur herstellung von (1r,4s)-2- azabicyclo 2.2.1 hept-5-en-3-on-derivaten
ATE220685T1 (de) Laktitolzusammensetzung und verfahren zu deren herstellung
ATE157282T1 (de) Verfahren zur herstellung einer aktiven zusammensetzung und damit hergestellte zusammensetzung
NO980371L (no) Framgangsmåte for framstilling av en lösning av N-metylmorfolin-N-oksid i vann
DE60039533D1 (de) Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
DE69821925D1 (de) Verfahren zur herstellung eines aminoalkohol
DE60014330D1 (de) Verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan
ES2019010A6 (es) Un procedimiento de resolucion optica de dropropizina racemica.
ATE253553T1 (de) Verfahren zur herstellung von 2- alkylthiobenzonitril-derivaten
ATE366255T1 (de) Verfahren zur herstellung halogenierter beta- lactamverbindungen
DE69519864D1 (de) Verfahren zur herstellung von chiralen tetrazyklischen dopaminergischen verbindungen
ZA971267B (en) Pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions containing them.
ATE256096T1 (de) Verfahren zur herstellung von 2- arylvinylalkylethern und 1,4-diaryl-2-fluor-2- butenen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee